Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

The enzyme immunoassays (EIAs) for antibody to human T-cell lymphotropic virus type III (HTLV-III) were rapidly adopted for screening donated blood and plasma. To evaluate the significance of a positive EIA reaction, test performance was examined in a blood bank screening program. Specimens were tested by EIA, Western blot assay, and HTLV-III/lymphadenopathy-associated virus (LAV) culture. The EIA was positive in 0.25% of 67 190 blood donations. Specimens were categorized and 57.3% had low (weak) reactivity, 12.7% had moderate reactivity, and 30.0% had high reactivity. Highly reactive specimens were strongly associated with a positive Western blot or culture (86.7%) in contrast to moderately and weakly reactive specimens (1.9%). Twenty-five of 29 donors interviewed with a highly reactive EIA had risk factors for HTLV-III/LAV infection. Risk factors were not identified for 74 of 75 interviewed donors with specimens of lower reactivity. The minimum calculated specificity was 99.82%. The use of the HTLV-III EIA has virtually eliminated the use of blood and plasma from HTLV-III/LAV infected donors.

[1]  E. S. Pearson,et al.  THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .

[2]  S. Weiss,et al.  The AIDS epidemic. , 1985, The New England journal of medicine.

[3]  P D Cumming,et al.  Prevalence of HTLV-III antibody in American blood donors. , 1985, The New England journal of medicine.

[4]  C. Marwick.  Use of AIDS antibody test may provide more answers. , 1985, JAMA.

[5]  W. Darrow,et al.  Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. , 1985, Annals of internal medicine.

[6]  M. Osterholm,et al.  Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? , 1985, The New England journal of medicine.

[7]  J. Chermann,et al.  Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome. , 1984, Science.

[8]  R. Biggar,et al.  Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. , 1984, British medical journal.

[9]  H. Jaffe,et al.  Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association. , 1985, JAMA.

[10]  S. Friedman,et al.  Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. , 1984, The New England journal of medicine.

[11]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[12]  D. Francis,et al.  Transfusion-associated AIDS: serologic evidence of human T-cell leukemia virus infection of donors. , 1984, Science.

[13]  M. Hirsch,et al.  Primary human T-lymphotropic virus type III infection. , 1985, Annals of internal medicine.

[14]  J. Esteban,et al.  IMPORTANCE OF WESTERN BLOT ANALYSIS IN PREDICTING INFECTIVITY OF ANTI-HTLV-III/LAV POSITIVE BLOOD , 1985, The Lancet.

[15]  Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. , 1985 .

[16]  V. Tsang,et al.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. , 1983, Methods in enzymology.

[17]  W. Darrow,et al.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study. , 1985, Annals of internal medicine.

[18]  S. Rastogi,et al.  Results of nationwide screening of blood and plasma for antibodies to human T‐cell lymphotrophic III virus, type III , 1986, Transfusion.

[19]  B. Safai,et al.  SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROME , 1984, The Lancet.

[20]  J. Goedert,et al.  Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications. , 1985, JAMA.

[21]  R. Redfield,et al.  HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS , 1984, The Lancet.

[22]  J. Goedert,et al.  HTLV-III infection among health care workers. Association with needle-stick injuries. , 1985, JAMA.

[23]  P. Kühnl,et al.  HLA DR4 ANTIBODIES CAUSE POSITIVE HTLV-III ANTIBODY ELISA RESULTS , 1985, The Lancet.

[24]  Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. , 1985, MMWR. Morbidity and mortality weekly report.

[25]  R. Gallo,et al.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[26]  R. Weinstein,et al.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions. , 1984, The New England journal of medicine.

[27]  R. Miller,et al.  Granulomatous angiitis presenting with polymyalgia rheumatica and abnormal pituitary function. , 1985, Annals of internal medicine.

[28]  J Schüpbach,et al.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. , 1984, Science.

[29]  F. Brun-Vézinet,et al.  Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. , 1984, The New England journal of medicine.